Ablatotech for Clinicians

Ablatotech Vitals

Concise, cited clinical evidence digests — AI-curated and reviewed by clinicians to help you keep up at the point of care.

Important. Ablatotech Vitals is an educational, reference-only publication. It is not medical advice and not a diagnostic tool, and it never processes patient-identifiable data. Always apply independent clinical judgement and consult primary sources and local guidelines.
New — Guideline & Interaction Assistant. Ask what the latest guidelines say for a condition, or check a drug against a second drug or a gene — with inline citations.
Open the assistant
New — Plain-Language Patient Explainer. Paste a diagnosis or medication regimen and get a patient-friendly handout at the reading level and language you choose.
Create a handout
New — Clinical Trial Finder & Matcher. Paste a de-identified clinical scenario and get currently recruiting trials from ClinicalTrials.gov, ranked by AI for eligibility fit.
Find recruiting trials
All specialties GeneralMedicine Oncology InfectiousDisease Cardiology Neurology Immunology Rheumatology Endocrinology Pediatrics RareDisease
GeneralMedicine EvidenceDigest

Evidence update on outpatient management of community-acquired pneumonia

Community-acquired pneumonia (CAP) remains a significant cause of morbidity and mortality worldwide. Recent evidence suggests that outpatient management of CAP can be effective and safe for select pat…

Reviewed by the Ablatotech Vitals editorial team · September 22, 2026 · 0 views
Oncology EvidenceDigest

Emerging biomarkers guiding first-line immunotherapy selection

The selection of first-line immunotherapy in oncology is increasingly guided by emerging biomarkers that may enhance patient outcomes. Biomarkers such as PD-L1 expression, tumor mutational burden (TMB…

Reviewed by the Ablatotech Vitals editorial team · September 22, 2026 · 0 views
InfectiousDisease EvidenceDigest

Updated evidence on shortened antibiotic courses for common infections

Recent studies suggest that shortened antibiotic courses may be effective for treating common infections, such as uncomplicated pneumonia, urinary tract infections (UTIs), and skin infections. These f…

Reviewed by the Ablatotech Vitals editorial team · September 22, 2026 · 0 views
Cardiology EvidenceDigest

SGLT2 inhibitors across the heart-failure ejection-fraction spectrum

SGLT2 inhibitors have emerged as a significant therapeutic option for patients with heart failure (HF) across the ejection fraction (EF) spectrum, including both reduced (HFrEF) and preserved (HFpEF) …

Reviewed by the Ablatotech Vitals editorial team · September 22, 2026 · 0 views
Neurology EvidenceDigest

Evidence update on anti-amyloid therapy for early Alzheimer disease

Anti-amyloid therapies have emerged as a focal point in the treatment of early Alzheimer disease (AD), with recent trials suggesting potential benefits in cognitive decline. However, the clinical sign…

Reviewed by the Ablatotech Vitals editorial team · September 22, 2026 · 0 views
Immunology EvidenceDigest

Biologic selection in moderate-to-severe atopic dermatitis

The selection of biologic therapies for moderate-to-severe atopic dermatitis (AD) should be guided by individual patient characteristics, including disease severity, comorbidities, and previous treatm…

Reviewed by the Ablatotech Vitals editorial team · September 22, 2026 · 0 views
Rheumatology EvidenceDigest

Treat-to-target evidence in early rheumatoid arthritis

The treat-to-target (T2T) strategy in early rheumatoid arthritis (RA) emphasizes achieving specific treatment goals, primarily remission or low disease activity, to improve long-term outcomes. Current…

Reviewed by the Ablatotech Vitals editorial team · September 22, 2026 · 0 views
Endocrinology EvidenceDigest

GLP-1 receptor agonists: cardiometabolic outcomes beyond glycemia

GLP-1 receptor agonists (GLP-1 RAs) have emerged as a promising therapeutic class not only for glycemic control in type 2 diabetes but also for their potential cardiometabolic benefits. Recent studies…

Reviewed by the Ablatotech Vitals editorial team · September 22, 2026 · 0 views
Pediatrics EvidenceDigest

Evidence-based management of pediatric acute otitis media

Acute otitis media (AOM) is a common pediatric condition characterized by the inflammation of the middle ear, often leading to pain and fever. Evidence suggests that management strategies should be ta…

Reviewed by the Ablatotech Vitals editorial team · September 22, 2026 · 0 views
RareDisease EvidenceDigest

Newborn screening advances for treatable rare metabolic disorders

Recent advances in newborn screening (NBS) technologies have significantly improved the early detection of treatable rare metabolic disorders. These advancements, particularly in tandem mass spectrome…

Reviewed by the Ablatotech Vitals editorial team · September 22, 2026 · 0 views